These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27899115)

  • 21. Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children.
    Dzinjalamala FK; Macheso A; Kublin JG; Taylor TE; Barnes KI; Molyneux ME; Plowe CV; Smith PJ
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3601-6. PubMed ID: 16127028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
    Tekete M; Djimde AA; Beavogui AH; Maiga H; Sagara I; Fofana B; Ouologuem D; Dama S; Kone A; Dembele D; Wele M; Dicko A; Doumbo OK
    Malar J; 2009 Feb; 8():34. PubMed ID: 19245687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
    Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
    Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology.
    Ballif M; Hii J; Marfurt J; Crameri A; Fafale A; Felger I; Beck HP; Genton B
    Malar J; 2010 Oct; 9():270. PubMed ID: 20925934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa.
    McCollum AM; Basco LK; Tahar R; Udhayakumar V; Escalante AA
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4089-97. PubMed ID: 18765692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
    Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh.
    van den Broek IV; van der Wardt S; Talukder L; Chakma S; Brockman A; Nair S; Anderson TC
    Trop Med Int Health; 2004 Jun; 9(6):680-7. PubMed ID: 15189458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine.
    Gatton ML; Cheng Q
    J Antimicrob Chemother; 2006 Jul; 58(1):47-51. PubMed ID: 16641113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
    Alker AP; Kazadi WM; Kutelemeni AK; Bloland PB; Tshefu AK; Meshnick SR
    Trop Med Int Health; 2008 Nov; 13(11):1384-91. PubMed ID: 19055622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
    Marfurt J; Smith TA; Hastings IM; Müller I; Sie A; Oa O; Baisor M; Reeder JC; Beck HP; Genton B
    Malar J; 2010 Jan; 9():8. PubMed ID: 20053293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations.
    Checchi F; Durand R; Balkan S; Vonhm BT; Kollie JZ; Biberson P; Baron E; Le Bras J; Guthmann JP
    Trans R Soc Trop Med Hyg; 2002; 96(6):664-9. PubMed ID: 12625147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
    Mockenhaupt FP; Teun Bousema J; Eggelte TA; Schreiber J; Ehrhardt S; Wassilew N; Otchwemah RN; Sauerwein RW; Bienzle U
    Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifolate antimalarial resistance in southeast Africa: a population-based analysis.
    Roper C; Pearce R; Bredenkamp B; Gumede J; Drakeley C; Mosha F; Chandramohan D; Sharp B
    Lancet; 2003 Apr; 361(9364):1174-81. PubMed ID: 12686039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau.
    Kofoed PE; Alfrangis M; Poulsen A; Rodrigues A; Gjedde SB; Rønn A; Rombo L
    Trop Med Int Health; 2004 Jan; 9(1):171-7. PubMed ID: 14728622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
    Mita T; Kaneko A; Hwaihwanje I; Tsukahara T; Takahashi N; Osawa H; Tanabe K; Kobayakawa T; Björkman A
    Infect Genet Evol; 2006 Nov; 6(6):447-52. PubMed ID: 16600696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.